Delivery of a foot-and-mouth disease virus empty capsid subunit antigen with nonstructural protein 2B improves protection of swine (Q39944822)

15 September 2017

title

Delivery of a foot-and-mouth disease virus empty capsid subunit antigen with nonstructural protein 2B improves protection of swine (English)

1 reference

foot-and-mouth disease virus

15 September 2017

main subject

foot-and-mouth disease

1 reference

based on heuristic

inferred from title

object named as

foot-and-mouth disease virus

1 reference

1 reference

15 September 2017

Fayna Diaz-San Segundo

object named as

Fayna Diaz-San Segundo

1 reference

15 September 2017

Marvin J Grubman

1 reference

15 September 2017

Lindomar Pena

1 reference

15 September 2017

Mauro Pires Moraes

1 reference

15 September 2017

Marla Koster

1 reference

15 September 2017

Thomas Burrage

1 reference

15 September 2017

language of work or name

English

0 references

publication date

30 August 2008

1 reference

15 September 2017

1 reference

15 September 2017

1 reference

15 September 2017

1 reference

15 September 2017

page(s)

5689-5699

1 reference

15 September 2017

cites work

Foot-and-mouth disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Global FMD control--is it an option?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Control and eradication of foot-and-mouth disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Foot-and-mouth disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Induction of membrane proliferation by poliovirus proteins 2C and 2BC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Membrane rearrangement and vesicle induction by recombinant poliovirus 2C and 2BC in human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Remodeling the endoplasmic reticulum by poliovirus infection and by individual viral proteins: an autophagy-like origin for virus-induced vesicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Multimerization reactions of coxsackievirus proteins 2B, 2C and 2BC: a mammalian two-hybrid analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

The ultrastructure of the developing replication site in foot-and-mouth disease virus-infected BHK-38 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Picornaviruses and cell death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

The coxsackievirus 2B protein suppresses apoptotic host cell responses by manipulating intracellular Ca2+ homeostasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Enterovirus protein 2B po(u)res out the calcium: a viral strategy to survive?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Nucleotide sequence and genome organization of foot-and-mouth disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Comparative genomics of foot-and-mouth disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Effects of foot-and-mouth disease virus nonstructural proteins on the structure and function of the early secretory pathway: 2BC but not 3A blocks endoplasmic reticulum-to-Golgi transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Differential distribution of non-structural proteins of foot-and-mouth disease virus in BHK-21 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Inhibition of the secretory pathway by foot-and-mouth disease virus 2BC protein is reproduced by coexpression of 2B with 2C, and the site of inhibition is determined by the subcellular location of 2C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Molecular epidemiology of foot-and-mouth disease virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Economic costs of the foot and mouth disease outbreak in the United Kingdom in 2001.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

New approaches to vaccination against foot-and-mouth disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

The application of new techniques to the improved detection of persistently infected cattle after vaccination and contact exposure to foot-and-mouth disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

pAd5-Blue: direct ligation system for engineering recombinant adenovirus constructs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

A continuous bovine kidney cell line for routine assays of foot-and-mouth disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

The infectivity assay of foot-and-mouth disease virus in pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Analysis of a foot-and-mouth disease virus type A24 isolate containing an SGD receptor recognition site in vitro and its pathogenesis in cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

The use of lead citrate at high pH as an electron-opaque stain in electron microscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Recombinant adenovirus co-expressing capsid proteins of two serotypes of foot-and-mouth disease virus (FMDV): in vitro characterization and induction of neutralizing antibodies against FMDV in swine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Poverty impacts of foot-and-mouth disease and the poverty reduction implications of its control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Regulation of poliovirus 3C protease by the 2C polypeptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Relationship between the anti-FMD virus antibody reaction as measured by different assays, and protection in vivo against challenge infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Foot and mouth disease vaccine potency tests in cattle: the interrelationship of antigen dose, serum neutralizing antibody response and protection from challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

The degree of apoptosis as an immunostimulant for a DNA vaccine against HIV-1 infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Direct comparison of antigen production and induction of apoptosis by canarypox virus- and modified vaccinia virus ankara-human immunodeficiency virus vaccine vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

The pathogenesis and diagnosis of foot-and-mouth disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Determinants of early foot-and-mouth disease virus dynamics in pigs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Alarmins: chemotactic activators of immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Immunostimulatory combinations: designing the next generation of vaccine adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

Systematic nomenclature of picornavirus proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

inferred from DOI database lookup

7 January 2021

based on heuristic

Poliovirus protein 2BC increases cytosolic free calcium concentrations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.022

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2008.08.022

1 reference

15 September 2017

1 reference